Criticaleye recently caught up with Abbas Hussain, President, Emerging Markets at GlaxoSmithKline, to discuss the state of emerging markets and the initial stages of GSK’s low-cost drug plan, a revolutionary scheme set to change the face of the pharmaceutical industry.
Read, watch & listen to some of the latest thought leadership from our Community.
BLOG | The CEO-CFO Partnership: Driving Strategic Alignment
The relationship between the CEO and CFO has never been more important. In a business environment defined by economic uncertainty, AI-driven transformation and heightened stakeholder expe...
Building an AI-Ready Workforce
AI is reshaping ways of working faster than most organisations can adapt, putting talent strategy at the top of the Board agenda. Criticaleye's Anna Mitchell asks Board Leaders and CPOs with hands-on experience o...
Richard Williams, Former CHRO at Western Union: How HR Becomes a Board-Level Power Function
Richard Williams, Board Mentor at Criticaleye and former Chief Human Resources Officer (CHRO) at Western Union joins Bridgette Hall, Senior Editor at Criticaleye to explore what it takes to lead HR in a global organi...
Displaying 1 to 3 of 202
We use cookies to improve your experience. By using our site, you agree to our use of cookies.
